The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public health risk.

After abortion opponents and doctors failed in their case to have the drug restricted — the Supreme Court ruled they lacked standing — Idaho, Kansas, and Missouri stepped in. Meanwhile, other states are making moves to protect reproductive rights.

The states of Idaho, Kansas and Missouri made the request in U.S. District Court in Amarillo, Texas. The only judge based there is Matthew Kacsmaryk, a nominee of former President

A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide.